1-6 of 6
Takeshi Kita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema

Takeshi Kita, Allen C. Clermont, Nivetha Murugesan, Qunfang Zhou, Kimihiko Fujisawa, Tatsuro Ishibashi, Lloyd Paul Aiello, Edward P. Feener
Journal: Diabetes
Diabetes 2015;64(10):3588–3599
https://doi.org/10.2337/db15-0317
Published: 15 May 2015
View article titled, Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema
Open the PDF for Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema in another window
Includes: Supplementary data
Journal Articles

Plasma Kallikrein Mediates Retinal Vascular Dysfunction and Induces Retinal Thickening in Diabetic Rats

Allen Clermont, Tamie J. Chilcote, Takeshi Kita, Jia Liu, Priscilla Riva, Sukanto Sinha, Edward P. Feener
Journal: Diabetes
Diabetes 2011;60(5):1590–1598
https://doi.org/10.2337/db10-1260
Published: 23 April 2011
View article titled, Plasma Kallikrein Mediates Retinal Vascular Dysfunction and Induces Retinal Thickening in Diabetic Rats
Open the PDF for Plasma Kallikrein Mediates Retinal Vascular Dysfunction and Induces Retinal Thickening in Diabetic Rats in another window
Includes: Supplementary data
Journal Articles

Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage

Ryoichi Arita, Yasuaki Hata, Shintaro Nakao, Takeshi Kita, Muneki Miura, Shuhei Kawahara, Souska Zandi, Lama Almulki, Faryan Tayyari, Hiroaki Shimokawa, Ali Hafezi-Moghadam, Tatsuro Ishibashi
Journal: Diabetes
Diabetes 2009;58(1):215–226
https://doi.org/10.2337/db08-0762
Published: 01 January 2009
View article titled, Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage
Open the PDF for Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage in another window
Journal Articles

Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins

Shuhei Kawahara, Yasuaki Hata, Takeshi Kita, Ryoichi Arita, Muneki Miura, Shintaro Nakao, Yasutaka Mochizuki, Hiroshi Enaida, Tadahisa Kagimoto, Yoshinobu Goto, Ali Hafezi-Moghadam, Tatsuro Ishibashi
Journal: Diabetes
Diabetes 2008;57(10):2784–2793
https://doi.org/10.2337/db08-0302
Published: 01 October 2008
View article titled, Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins
Open the PDF for Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins in another window
Journal Articles

Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells

Takeshi Kita, Yasuaki Hata, Muneki Miura, Shuhei Kawahara, Shintaro Nakao, Tatsuro Ishibashi
Journal: Diabetes
Diabetes 2007;56(5):1421–1428
https://doi.org/10.2337/db06-1644
Published: 01 May 2007
View article titled, Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells
Open the PDF for Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells in another window
Journal Articles

Transforming Growth Factor-β2 and Connective Tissue Growth Factor in Proliferative Vitreoretinal Diseases: Possible Involvement of Hyalocytes and Therapeutic Potential of Rho Kinase Inhibitor

Takeshi Kita, Yasuaki Hata, Kumiko Kano, Muneki Miura, Shintaro Nakao, Yoshihiro Noda, Hiroaki Shimokawa, Tatsuro Ishibashi
Journal: Diabetes
Diabetes 2007;56(1):231–238
https://doi.org/10.2337/db06-0581
Published: 01 January 2007
View article titled, Transforming Growth Factor-β2 and Connective Tissue Growth Factor in Proliferative Vitreoretinal Diseases: <subtitle>Possible Involvement of Hyalocytes and Therapeutic Potential of Rho Kinase Inhibitor</subtitle>
Open the PDF for Transforming Growth Factor-β2 and Connective Tissue Growth Factor in Proliferative Vitreoretinal Diseases: <subtitle>Possible Involvement of Hyalocytes and Therapeutic Potential of Rho Kinase Inhibitor</subtitle> in another window